VOR

VOR BIOPHARMA INC

VOR·929033207·US·Common Stock·Healthcare - Biotechnology-Activist

VOR (VOR BIOPHARMA INC) is held by 41 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($96.4M), FMR LLC ($27.5M), VANGUARD CAPITAL MANAGEMENT LLC ($25.6M). Net institutional sentiment: Bullish.

41
Holders
Avg rating(5 Elite)
$257.2M
Total Value
74% (45)
Fund Consensus
31 buying - 11 selling
VORSmart Money Verdict
View all
Held by 41 funds
5 elite
Who's Trading
ActivistVHVenrock Healthcare Capital Partners III, L.P.9.9%May 15, 2026
ActivistVEVerve Capital Limited9.3%May 15, 2026
ActivistFMR LLCFMR LLC3.2%May 6, 2026
ActivistQVQiming Venture Partners VIII-HC, L.P.2.0%May 6, 2026
InsiderRLRA CAPITAL MANAGEMENT, L.P.Sell $2.6MApr 22, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.19.9%Apr 21, 2026
InsiderRLRA CAPITAL MANAGEMENT, L.P.Sell $2.7MApr 20, 2026
InsiderRLRA CAPITAL MANAGEMENT, L.P.Sell $7.5MApr 17, 2026
InsiderRLRA CAPITAL MANAGEMENT, L.P.Sell $859KApr 15, 2026
InsiderRLRA CAPITAL MANAGEMENT, L.P.Sell $2.5MApr 14, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
5.4M$96.4M1.0%-82.00%
0
Decreased
1.5M(-39.0%)$27.5M0.0%+40.89%
0
New
1.4M$25.6M0.0%+28.03%
40
New
1.2M$20.6M0.0%+28.03%
39
Increased
1.1M(+1128.4%)$20M0.0%+27.45%
46
Increased
794,759(+70.7%)$14.2M0.0%+36.50%
42
Increased
488,368(+67.2%)$8.7M0.0%+28.93%
41
Increased
342,573(+84.4%)$6.1M0.0%-19.45%
42
Increased
261,891(+79.8%)$4.7M0.0%+36.42%
41
Increased
258,587(+15.2%)$4.6M0.0%+23.73%
31
Increased
232,608(+1469.7%)$4.1M0.0%+29.36%
43
New
185,511$3.3M0.0%+28.03%
37
Decreased
152,571(-9.0%)$2.7M0.0%+52.75%
0
Decreased
148,768(-65.7%)$2.7M0.0%+48.50%
0
New
128,839$2.3M0.0%+28.03%
36
Increased
116,721(+310.1%)$2.1M0.0%+24.83%
42
Increased
112,892(+284x)$2M0.0%+27.34%
42
New
95,745$1.7M0.0%+28.03%
36
Increased
76,630(+186.0%)$1.4M0.0%+35.71%
41
Decreased
75,890(-17.3%)$1.4M0.0%+39.74%
0

Showing 1-20 of 45

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used